The model included an adaptive immune response, namely CD8+ cytotoxic T cells, CD4+ Th1 cells, and CD4+ Th2 cells in a 2D vascularized network grid with hypoxic and proliferating tumor regions. This evidence concerns the gene CD4 and neoplasm.